Identify the Risk of Acute Kidney Injury—Before It’s a Problem
The NephroCheck® Test was created for use alongside clinical evaluation of intensive care patients over 21 who have or have had acute cardiovascular and/or respiratory compromise in the past 24 hours. With results in just 20 minutes, the test is intended to assist the clinician in assessing the risk of moderate to severe acute kidney injury in the next 12 hours.
Identify, stratify and mitigate
the risk of acute kidney injury
Identify
Stratify
Mitigate
Why is early identification of AKI important?
Dr. Peter McCullough discusses how early identification is fundamental for treating acute kidney injury. The NephroCheck® Test can help inform certain adjustments to critical care management.
Click here to implementA Renal “Alarm System”
The NephroCheck® Test produces a single numerical AKIRisk® Score in a reportable range of 0.04 to 10.0. Patients whose score exceeds 0.3 are considered to be at risk of developing acute kidney injury.
The NephroCheck® Test cutoff of > 0.3 was prospectively selected prior to validation studies to achieve*:
- High sensitivity
- Acceptable specificity
- High negative predictive value for AKIRisk® Score of ≤ 0.3
High sensitivity and negative predictive value ensure that:
- The majority of patients who will develop AKI test positive
- Few patients with a negative test result will be at risk of developing AKI
*Moderate to severe AKI in the next 12 hours.
Spotting at risk patients
The NephroCheck® Test demonstrates significant discrimination between patients with and without AKI. There is no elevation of test results by chronic comorbidities or non-AKI acute conditions (relative to apparently healthy subjects).
Simple Procedure
